دورية أكاديمية

Saliva as a Biological Fluid in SARS-CoV-2 Detection.

التفاصيل البيبلوغرافية
العنوان: Saliva as a Biological Fluid in SARS-CoV-2 Detection.
المؤلفون: Silva, Emily Thalia Teixeira, Furtado, Fabiana Barcelos, Silveira, Rosana Antunes da, Tasca, Karen Ingrid, Silva, Cristiane Nonato, Godoy, Amanda Thais, Moraes, Leonardo Nazario de, Hong, Michelle Venancio, Alves, Camila Gonçalves, Simões, Rafael Plana, Kubo, Agatha Mayume Silva, Fortaleza, Carlos Magno Castelo Branco, Pereira-Lima, Maria Cristina, Valente, Guilherme Targino, Grotto, Rejane Maria Tommasini
المصدر: Diagnostics (2075-4418); May2024, Vol. 14 Issue 9, p922, 10p
مصطلحات موضوعية: SALIVA, COVID-19 pandemic, SARS-CoV-2, VACCINATION status, POLYMERASE chain reaction
مستخلص: Background: The polymerase chain reaction of upper respiratory tract swab samples was established as the gold standard procedure for diagnosing SARS-CoV-2 during the COVID pandemic. However, saliva collection has attracted attention as an alternative diagnostic collection method. The goal of this study was to compare the use of saliva and nasopharyngeal swab (NPS) samples for the detection of SARS-CoV-2. Methods: Ninety-nine paired samples were evaluated for the detection of SARS-CoV-2 by saliva and swab for a qualitative diagnosis and quantitative comparison of viral particles. Furthermore, the detection limits for each sample collection technique were determined. The cycle threshold (CT) values of the saliva samples, the vaccination status, and the financial costs associated with each collection technique were compared. Results: The results showed qualitative equivalence in diagnosis (96.96%) comparing saliva and swab collection, although there was low quantitative agreement. Furthermore, the detection limit test demonstrated equivalence for both collection methods. We did not observe a statistically significant association between CT values and vaccination status, indicating that the vaccine had no influence on viral load at diagnosis. Finally, we observed that the use of saliva incurs lower financial costs and requires less use of plastic materials, making it more sustainable. Conclusions: These findings support the adoption of saliva collection as a feasible and sustainable alternative to the diagnosis of COVID-19. [ABSTRACT FROM AUTHOR]
Copyright of Diagnostics (2075-4418) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20754418
DOI:10.3390/diagnostics14090922